Literature DB >> 2759974

Mathematical analysis of running performance and world running records.

F Péronnet1, G Thibault.   

Abstract

The objective of this study was to develop an empirical model relating human running performance to some characteristics of metabolic energy-yielding processes using A, the capacity of anaerobic metabolism (J/kg); MAP, the maximal aerobic power (W/kg); and E, the reduction in peak aerobic power with the natural logarithm of race duration T, when T greater than TMAP = 420 s. Accordingly, the model developed describes the average power output PT (W/kg) sustained over any T as PT = [S/T(1 - e-T/k2)] + 1/T integral of T O [BMR + B(1 - e-t/k1)]dt where S = A and B = MAP - BMR (basal metabolic rate) when T less than TMAP; and S = A + [Af ln(T/TMAP)] and B = (MAP - BMR) + [E ln(T/TMAP)] when T greater than TMAP; k1 = 30 s and k2 = 20 s are time constants describing the kinetics of aerobic and anaerobic metabolism, respectively, at the beginning of exercise; f is a constant describing the reduction in the amount of energy provided from anaerobic metabolism with increasing T; and t is the time from the onset of the race. This model accurately estimates actual power outputs sustained over a wide range of events, e.g., average absolute error between actual and estimated T for men's 1987 world records from 60 m to the marathon = 0.73%. In addition, satisfactory estimations of the metabolic characteristics of world-class male runners were made as follows: A = 1,658 J/kg; MAP = 83.5 ml O2.kg-1.min-1; 83.5% MAP sustained over the marathon distance. Application of the model to analysis of the evolution of A, MAP, and E, and of the progression of men's and women's world records over the years, is presented.

Entities:  

Mesh:

Year:  1989        PMID: 2759974     DOI: 10.1152/jappl.1989.67.1.453

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  56 in total

Review 1.  Interval training for performance: a scientific and empirical practice. Special recommendations for middle- and long-distance running. Part II: anaerobic interval training.

Authors:  L V Billat
Journal:  Sports Med       Date:  2001-02       Impact factor: 11.136

Review 2.  Modelling human locomotion: applications to cycling.

Authors:  T Olds
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 3.  Training techniques to improve endurance exercise performances.

Authors:  Zuko N Kubukeli; Timothy D Noakes; Steven C Dennis
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 4.  Methods to determine aerobic endurance.

Authors:  Laurent Bosquet; Luc Léger; Patrick Legros
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

5.  The VO2 response to exhaustive square wave exercise: influence of exercise intensity and mode.

Authors:  S B Draper; D M Wood; J L Fallowfield
Journal:  Eur J Appl Physiol       Date:  2003-07-17       Impact factor: 3.078

Review 6.  Temporal changes in long-distance running performance of Asian children between 1964 and 2009.

Authors:  Grant R Tomkinson; Duncan Macfarlane; Shingo Noi; Dae-Yeon Kim; Zhengzhen Wang; Ren Hong
Journal:  Sports Med       Date:  2012-04-01       Impact factor: 11.136

Review 7.  An analysis of performance in human locomotion.

Authors:  Guido Ferretti; Aurélien Bringard; Renza Perini
Journal:  Eur J Appl Physiol       Date:  2010-05-01       Impact factor: 3.078

Review 8.  Gold Standard or Fool's Gold? The Efficacy of Displacement Variables as Indicators of Energy Expenditure in Team Sports.

Authors:  Ted Polglaze; Brian Dawson; Peter Peeling
Journal:  Sports Med       Date:  2016-05       Impact factor: 11.136

9.  The VO2 response for an exhaustive treadmill run at 800-m pace: a breath-by-breath analysis.

Authors:  S B Draper; D M Wood
Journal:  Eur J Appl Physiol       Date:  2004-11-23       Impact factor: 3.078

Review 10.  The critical power and related whole-body bioenergetic models.

Authors:  R Hugh Morton
Journal:  Eur J Appl Physiol       Date:  2005-11-12       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.